Latest News and Press Releases
Want to stay updated on the latest news?
-
Translational Research in Oncology (TRIO) Enrolls First Patient in Early Breast Cancer Phase 2 Trial
EDMONTON, Alberta, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment of the first patient in a...
-
EDMONTON, Alberta, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced the appointment of two new members...
-
EDMONTON, Alberta, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced enrolment of the first patient in a...
-
EDMONTON, Alberta, April 25, 2019 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced it has partnered with Molecular...
-
Эдмонтон, Альберта, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) в сотрудничестве с Novartis и под руководством доктора медицинских наук, председателя правления и...
-
EDMONTON, Alberta, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO), in collaboration with Novartis and under the direction of Dennis Slamon, MD, PhD, TRIO...
-
EDMONTON, Alberta, July 09, 2018 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) today announced a collaboration with Novartis on its upcoming phase III clinical trial of ribociclib...
-
EDMONTON, Alberta, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO) is pleased to announce its participation in the Avoca Diligent™ Prequalification Platform. The purpose...